Search Results

You are looking at 1 - 10 of 43 items for :

  • pharmacokinetics x
  • Internal Medicine, other x
Clear All
Open access

Olorunfemi Eseyin, Aniekan Ebong, Anefiok Ubobre, Johnson Ekarika and Imo Udo

chloroquine sulphate and aqueous extract of Azadirachta indica A Juss (Meliaceae) in rabbits. Acta Pharmaceutica. 2003;53(4):305-11. 8. O’Brien D, Haddad AR. Consulting patients on drug-food interactions. U. S. Pharmacist. 2002;22(6). 9. Eseyin OA, Edoho EJ, Igboasoiyi AC, Nwadiukwu E, Ekpo A. Effects of the leaf extract of Telfairia occidentalis on the pharmacokinetic of chloroquine. International Journal of Biological Chemistry. 2007;1(4):256-260. 10. Igboasoiyi AC, Eseyin OA, Udoma NF. The effect of ethanolic extract of

Open access

Dan Andonie, Zsolt Gáll, Paul Bosa, Maria Titica Dogaru and Szende Vancea

carbamazepine in serum and saliva samples by high performance liquid chromatography with ultraviolet detection Odre đ ivanje karbamazepina u uzorcima seruma i salive primenom te č ne hromatografije visokih performansi sa ultravioletnom de. Vojn Pregl . 2009;66:347-352. 18. Krasowski MD, McMillin GA. Advances in anti-epileptic drug testing. Clin Chim Acta . 2014;436:224-236. 19. Beig A, Dahan A. Quantification of carbamazepine and its 10,11-epoxide metabolite in rat plasma by UPLC-UV and application to pharmacokinetic study. Biomed Chromatogr . 2014

Open access

Patrick M. Honoré, Rita Jacobs, Elisabeth De Waele, Jouke De Regt, Thomas Rose and Herbert D. Spapen

References 1. Sefar S, Degoricija V. About drug dialyzability. Acta Clin Croat 2003;42:257-26. 2. Al-Habet SM, Rogers HJ. Methylprednisolone pharmacokinetics after intravenous and oral administration. Br J Clin Pharmacol 1989;27:285-90. 3. Venkatesh B, Myburgh J, Finfer S, Webb SA, Cohen J, Bellomo R, et al. The ADRENAL study protocol: Adjunctive corticosteroid treatment in critically ill patients with septic shock. Crit Care Resusc 2013;15:83-8. 4. Frey BM, Frey FJ. Clinical pharmacokinetics of

Open access

Oleh Yadlovskiy, Tatiana Bukhtiarova and Anatoliy Demchenko

Pharmacology of (R)- and (S)- Ketorolac. J Clin Pharmacol. 1998; 38: 25-35. 8. King TE, Joynes RL, Grau JW Tail-flick test: II. The role of supraspinal systems and avoidance learning. Behav Neurosci . 1997;111:754-767. 9. Komlos E, Porsresr J, Knole J.Morfin - prostigmin synergismus. Az. Acta. Phisiologica. Acad. Scient. Hungaricae.-1950;1: 77-83. 10. Lugo RA, Kern SE. Clinical pharmacokinetics of morphine. J. Pain Palliat Care Pharmacother. 2002; 16(4): 5-18. 11. Mathias SD, Kuppermann M, Liberman RF, Lipschutz

Open access

Odusoga Osonuga and Ifabunmi Osonuga

White NJ. Clinical pharmacokinetics of antimalarial drugs. Clin Pharmacokinet. 1985;10(3):187-215. doi:10.2165/00003088-198510030-00001 PMID:3893840 Hosein S. Infection fighters - Artemisia - experience. Treatment information Exchange. Canada Update 60. Vol 7.

Open access

Tatjana Petrushevska

Report 2010. http:// www.emcdda.europa.eu/events/2010/annual-report. 29. Farrell M. National Addiction Centre, Institute of Psychiatry, London SE5 8AF Wayne Hall. The Swiss heroin trials: testing alternative approaches BMJ. 1998;316(7132): 639. 30. Carnwath T, Merrill J. Dose equivalents in opioid substitution treatment. International Journal of Drug Policy. 2002;13:445-447. 31. Rook EJ, Huitema AD, van den Brink W, van Ree JM, Beijnen JH. Pharmacokinetics and pharmacokinetic variability of heroin and its metabolites

Open access

Jordan Minov, Jovanka Karadzinska-Bislimovska, Tatjana Petrova, Kristin Vasilevska, Snezana Risteska-Kuc, Saso Stoleski and Dragan Mijakoski

chronic obstructive pulmonary disease after treatment with antimicrobials: a results of a two-years study. IMPAC Study Group. Clin Drug Invest. 2003;23:439-450. doi:10.2165/00044011-200323070-00003 PMID:17535055 Perry CM, Brogden RN. Cefuroxime Axetil. A review of its antibacterial activity, pharmacokinetic properties and therapeutic efficacy. Drugs. 1996;52(1):125-156. doi:10.2165/00003495-199652010-00009 PMID:8799689 Destache CJ, Dewan N, O'Donohue WJ, et al. Clinical and economic considerations in the

Open access

Elida Mitevska and Mirko Spiroski

;3(2):123-131. Blossey HC, Wander HE, Koebberling J, Nagel GA, Pharmacokinetic and pharmacodynamic basis for the treatment of metastatic breast cancer with high-dose medroxyprogesterone acetate. Cancer. 1984;54:1208-1215. Van Veelen H, Willemse PH, Sleijfer DT, Van der Ploeg E, Sluiter WJ, Doorenbos H. Mechanism of adrenal suppresion by high-dose medroxy-progesterone acetate in breast cancer patients. Cancer Chemother Pharmacol. 1985;15(2):167-170. Barbieri RL, Ryan KJ. Direct effects of medroxyprogesterone acetate (MPA) and

Open access

Elida Mitevska and Mirko Spiroski

medroxyprogesterone acetate on the pituitary-adrenal axis. J Clin Endocrinol Metab. 1976;42(5):912-7. doi:10.1210/jcem-42-5-912 PMID:178684. Blossey HC, Wander HE, Koebberling J, Nagel GA. Pharmacokinetic and pharmacodynamic basis for the treatment of metastatic breast cancer with high-dose medroxyprogesterone acetate. Cancer. 1984;54(6 Suppl):1208-15. doi:10.1002/1097-0142(19840915)54:1+<1208::AID-CNCR2820541319>3.0.CO;2-K PMID:6088020. van Veelen H, Willemse PH, Sleijfer DT, van der Ploeg E, Sluiter WJ, Doorenbos H. Mechanism

Open access

Jordan Minov, Jovanka Karadzinska-Bislimovska, Tatjana Petrova, Kristin Vasilevska, Sasho Stoleski, Dragan Mijakoski and Snezhana Risteska-Kuc

outpatient acute exacerbations of COPD: MAESTRAL results. Eur Respir J. 2012;40(1):17-27. 31. Siempos II, Dimopoulos G, Korbila JP, Manta K, Falagas ME. Macrolides, quinolones and amoxicillin/clavulonate for chronic bronchitis: meta-analysis. Eur Respir J. 2007; 29 (6): 1127-1137. 32. Perry CM, Brogden RN. Cefuroxime Axetil. A review of its antibacterial activity, pharmacokinetic properties and therapeutic efficacy. Drugs. 1996; 52 (1): 125-156. 33. Destache CJ, Dewan N, O’Donohue WJ, Campbell JC, Anqelillo VA. Clinical and